Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial

IMPORTANCE: Fenfluramine treatment may reduce monthly convulsive seizure frequency in patients with Dravet syndrome who have poor seizure control with their current stiripentol-containing antiepileptic drug regimens. OBJECTIVE: To determine whether fenfluramine reduced monthly convulsive seizure fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabbout, Rima, Mistry, Arun, Zuberi, Sameer, Villeneuve, Nathalie, Gil-Nagel, Antonio, Sanchez-Carpintero, Rocio, Stephani, Ulrich, Laux, Linda, Wirrell, Elaine, Knupp, Kelly, Chiron, Catherine, Farfel, Gail, Galer, Bradley S., Morrison, Glenn, Lock, Michael, Agarwal, Anupam, Auvin, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902175/
https://www.ncbi.nlm.nih.gov/pubmed/31790543
http://dx.doi.org/10.1001/jamaneurol.2019.4113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902175/
https://www.ncbi.nlm.nih.gov/pubmed/31790543
http://dx.doi.org/10.1001/jamaneurol.2019.4113

Ejemplares similares